Evidence map›Paper›PMID 24969970›Full record

ArticleNature communications2014

Structural insight into SUMO chain recognition and manipulation by the ubiquitin ligase RNF4.

Yingqi Xu, Anna Plechanovová, Peter Simpson, Jan Marchant, Orsolya Leidecker, Sebastian Kraatz, Ronald T Hay, Steve J Matthews

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. The physical and evolutionary energy landscapes of devolved protein sequences corresponding to pseudogenes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yingqi Xu1] Centre for Structural Biology, Department of Life Sciences, Imperial College London, South Kensington, London SW7 2AZ, UK [2].
Anna Plechanovová1] Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK [2].
Peter SimpsonCentre for Structural Biology, Department of Life Sciences, Imperial College London, South Kensington, London SW7 2AZ, UK.
Jan MarchantCentre for Structural Biology, Department of Life Sciences, Imperial College London, South Kensington, London SW7 2AZ, UK.
Orsolya LeideckerCentre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
Sebastian KraatzCentre for Structural Biology, Department of Life Sciences, Imperial College London, South Kensington, London SW7 2AZ, UK.
Ronald T HayCentre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
Steve J MatthewsCentre for Structural Biology, Department of Life Sciences, Imperial College London, South Kensington, London SW7 2AZ, UK.
Imperial College London · GBUniversity of Dundee · GB

Funding

Biotechnology and Biological Sciences Research Council 016799Medical Research Council MR/J006874/1Wellcome Trust 085464Wellcome Trust 097945Wellcome Trust 098391Wellcome Trust 100280
6 · The paper itself

Abstract

The small ubiquitin-like modifier (SUMO) can form polymeric chains that are important signals in cellular processes such as meiosis, genome maintenance and stress response. The SUMO-targeted ubiquitin ligase RNF4 engages with SUMO chains on linked substrates and catalyses their ubiquitination, which targets substrates for proteasomal degradation. Here we use a segmental labelling approach combined with solution nuclear magnetic resonance (NMR) spectroscopy and biochemical characterization to reveal how RNF4 manipulates the conformation of the SUMO chain, thereby facilitating optimal delivery of the distal SUMO domain for ubiquitin transfer.

Indexed as

Protein Interaction MappingAmino Acid MotifsHumansNuclear ProteinsProteasome Endopeptidase ComplexSmall Ubiquitin-Related Modifier ProteinsTranscription FactorsUbiquitinationNuclear ProteinsProteasome Endopeptidase ComplexRNF4 protein, humanSmall Ubiquitin-Related Modifier ProteinsSUMO2 protein, humanTranscription Factors

Identifiers

PMID24969970
PMCPMC4083429
OpenAlexW2140898599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.